Together, our data implied the potential of EREG expression intensity in tumor stroma as an SASP-specific and tumor-independent predictor in clinics, which can be used to stratify the risk of disease relapse and clinical mortality in post-treatment patients, and suggested a likely causal role of stromal EREG in tumor progression. Here, EREG is linked to neoplasm.